# Embody

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/embody

- Industry: Medical Devices & Equipment
- Headquarters: Norfolk, US
- Website: www.embody-inc.com
- Total disclosed funding: $10M
- Latest round: Series C (Jul 23, 2022)
- Investors on record: 1

## About

Embody, Inc., based in the US, specializes in creating ergonomic products that enhance user comfort and wellness, targeting both personal and professional environments.Founded in 2015, Embody, Inc. develops innovative solutions to improve ergonomics. The company has not undergone any strategic pivots and operates independently. The founder, Jeff Conroy, has not been noted for other ventures. Embody is headquartered in Norfolk, US and has completed a total of 7 deals, with the most recent deal occurring on January 5, 2023, during a TRADE SALE where Zimmer Biomet Holdings, Inc. acquired Embody for USD 154.60 mn, including USD 19.60 mn in cash and USD 135 mn in shares.Embody, Inc. specializes in the development of innovative products aimed at enhancing user experience in various applications, focusing on sectors such as health, wellness, and lifestyle enhancement. The company's core offerings revolve around advanced technologies designed to improve ergonomics and comfort in both personal and professional environments. By integrating user-centric design principles, Embody's products address common issues such as posture, physical strain, and overall well-being. The primary customer base includes businesses in the corporate sector, wellness centers, and individual consumers looking for solutions to enhance their daily living and working conditions. Embody’s products are marketed across North America and Europe.Embody, Inc. generates revenue through a diverse array of business transactions, primarily structured as direct-to-consumer sales and B2B partnerships with corporations and wellness facilities. The company's flagship products command a premium price point, reflecting their unique design and performance features. Typical transactions involve clients purchasing products directly through established sales channels, with potential for bulk purchases by organizations seeking to equip their workplaces with ergonomic solutions. Additionally, Embody may engage in partnerships with retailers that facilitate wider distribution of their offerings. This multi-faceted approach to revenue generation enables the company to effectively reach its target market while supporting sustained growth.Following the acquisition by Zimmer Biomet Holdings, Inc. in February 2023, which was finalized for USD 154.60 mn, Embody is positioned to explore new product lines and expansion into additional markets. The acquisition aims to enhance long-term growth and create value. Plans include the design of new ergonomic solutions with anticipated launches in the upcoming year, alongside potential geographic expansion into Asia and South America by mid-2024. The recent funding will facilitate these initiatives, enabling Embody to strengthen its market presence and broaden its customer base.

## Funding rounds

- Series C, Jul 23, 2022, $10M — Genesis Innovation Group

## Investors

- Genesis Innovation Group (https://capitalatlas.ai/funds/genesis-innovation-group) — Series C